Crossmark

Molecular signature of response to preoperative radiotherapy in locally advanced breast cancer

Crossref DOI link: https://doi.org/10.1186/s13014-018-1129-4

Published Online: 2018-10-01

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tanić, Miljana http://orcid.org/0000-0003-3102-776X
Krivokuća, Ana

Čavić, Milena

Mladenović, Jasmina

Plesinac Karapandžić, Vesna

Beck, Stephan

Radulović, Siniša

Susnjar, Snezana

Janković, Radmila
Funding

Funding for this research was provided by:

Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (III 41026, OI 172017, OI 172030)

L'Oreal/UNESCO “For Women in Science” Award 2013 (2013 Call)

FP7 People: Marie-Curie Actions (FP7/2007-2013/608765)
License Information

Text and Data Mining valid from 2018-10-01
More Information

Article History

Received: 30 March 2018

Accepted: 12 September 2018

First Online: 1 October 2018

Ethics approval and consent to participate

: All patients gave their informed written consent for the use of residual tissue for research. The study was approved by the Institute of Oncology and Radiology Ethical Review Board for human studies.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.